Comparing Prognostic Performance of SEPSIS 2 and SEPSIS 3 Strategies at the Emergency Service (StraSEP)

In 2016, the Third International Consensus proposed a new strategy to screen aggravating risk in patients with septic shock. This strategy is based on quick-SOFA and the SOFA score. The main objective is to compare the prognostic performance of SEPSIS 3 against the previous strategy SEPSIS 2 to predict the admission in intensive care unit or the intra-hospital death.

Study Overview

Status

Completed

Conditions

Detailed Description

This study compare the prognostic performance of two strategies. It's a monocentric, retrospective study in patients admitted to the emergency department.

Study Type

Observational

Enrollment (Actual)

228

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Retrospective study in patients admitted to the emergency department in the CHR Metz-Thionville

Description

Inclusion Criteria:

  • Aged of 18 years or more
  • Initiation of one or more antibiotics in the Accident and Emergency Department in the Metz-Thionville hospital (CHR) site Mercy, for curative purpose, regardless of the infectious aetiology
  • Hospitalized in the CHR Metz-Thionville thereafter

Exclusion Criteria:

  • Minors patients
  • Absence of antibiotic treatment initiated in the Emergency department
  • Prescription of antibiotic treatment in the emergency department for preventive purpose
  • Transferred by hospitalisation service of CHR Metz-Thionville in the emergency department
  • Absence of hospitalisation following their passage through the emergency department
  • Transferred to hospitalisation in an other establishment
  • Presence, at the admission, of an antibiotic treatment
  • Patients deceased in the emergency department

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intrinsic and Extrinsic properties of SEPSIS 3 strategy
Time Frame: Day 1
The percentage of patients with high qSOFA score (2 or more) who were admitted in intensive care unit or who have died during their stay in hospital and rather the percentage of patients with a small qSOFA score who survived without passing through intensive care unit
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between lactate levels and mortality
Time Frame: Day 1
lactate levels at their admission
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

August 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

November 20, 2017

First Submitted That Met QC Criteria

November 22, 2017

First Posted (Actual)

November 28, 2017

Study Record Updates

Last Update Posted (Actual)

August 24, 2023

Last Update Submitted That Met QC Criteria

August 23, 2023

Last Verified

November 1, 2017

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

3
Subscribe